| Dr Ellsworth Raymond Grant, MD | |
|
1245 Wilshire Blvd, Suite 801, Los Angeles, CA 90017-4810 | |
| (213) 481-3948 | |
| (213) 481-1697 |
| Full Name | Dr Ellsworth Raymond Grant |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 34 Years |
| Location | 1245 Wilshire Blvd, Los Angeles, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043233760 | NPI | - | NPPES |
| 954893061 | Other | CA | TAX ID NO. |
| 00G730841 | Medicaid | CA | |
| 00G730842 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | G73084 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Hospital | Los angeles, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Oncology Institute Ca, A Professional Corporation | 5698872398 | 69 |
News Archive
Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the company's plan to open a new office facility in Austin, Texas, April 1, 2010. The new facility provides Pioneer greater recruiting access to industry professionals who will help further the growth and development of Pioneer's Spine Division.
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited.
A new study finds surgery to transplant an ovary to the upper arm is feasible and preserves hormonal function in women undergoing treatment for cervical cancer.
WuXi PharmaTech (Cayman) Inc. today announced that it filed its annual report on Form 20-F for the year ended December 31, 2009 with the Securities and Exchange Commission.
German experts recently explained why the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant is more infectious and pathogenic than its ancestor. By conducting a series of in vitro experiments, they have revealed that increased ability to induce cell-to-cell fusion (syncytia) and reduced susceptibility to vaccine and infection-induced antibodies make the delta variant more infectious than previously circulating variants. The study is currently available on the bioRxiv* preprint server.
› Verified 7 days ago
| Entity Name | The Oncology Institute Ca, A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275651515 PECOS PAC ID: 5698872398 Enrollment ID: O20070514000607 |
News Archive
Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the company's plan to open a new office facility in Austin, Texas, April 1, 2010. The new facility provides Pioneer greater recruiting access to industry professionals who will help further the growth and development of Pioneer's Spine Division.
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited.
A new study finds surgery to transplant an ovary to the upper arm is feasible and preserves hormonal function in women undergoing treatment for cervical cancer.
WuXi PharmaTech (Cayman) Inc. today announced that it filed its annual report on Form 20-F for the year ended December 31, 2009 with the Securities and Exchange Commission.
German experts recently explained why the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant is more infectious and pathogenic than its ancestor. By conducting a series of in vitro experiments, they have revealed that increased ability to induce cell-to-cell fusion (syncytia) and reduced susceptibility to vaccine and infection-induced antibodies make the delta variant more infectious than previously circulating variants. The study is currently available on the bioRxiv* preprint server.
› Verified 7 days ago
| Entity Name | Ellsworth Grant, M.d., Medical Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538247424 PECOS PAC ID: 9335200476 Enrollment ID: O20081208000082 |
News Archive
Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the company's plan to open a new office facility in Austin, Texas, April 1, 2010. The new facility provides Pioneer greater recruiting access to industry professionals who will help further the growth and development of Pioneer's Spine Division.
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited.
A new study finds surgery to transplant an ovary to the upper arm is feasible and preserves hormonal function in women undergoing treatment for cervical cancer.
WuXi PharmaTech (Cayman) Inc. today announced that it filed its annual report on Form 20-F for the year ended December 31, 2009 with the Securities and Exchange Commission.
German experts recently explained why the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant is more infectious and pathogenic than its ancestor. By conducting a series of in vitro experiments, they have revealed that increased ability to induce cell-to-cell fusion (syncytia) and reduced susceptibility to vaccine and infection-induced antibodies make the delta variant more infectious than previously circulating variants. The study is currently available on the bioRxiv* preprint server.
› Verified 7 days ago
| Entity Name | County Of Los Angeles |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1780877613 PECOS PAC ID: 1850296534 Enrollment ID: O20090713000358 |
News Archive
Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the company's plan to open a new office facility in Austin, Texas, April 1, 2010. The new facility provides Pioneer greater recruiting access to industry professionals who will help further the growth and development of Pioneer's Spine Division.
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited.
A new study finds surgery to transplant an ovary to the upper arm is feasible and preserves hormonal function in women undergoing treatment for cervical cancer.
WuXi PharmaTech (Cayman) Inc. today announced that it filed its annual report on Form 20-F for the year ended December 31, 2009 with the Securities and Exchange Commission.
German experts recently explained why the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant is more infectious and pathogenic than its ancestor. By conducting a series of in vitro experiments, they have revealed that increased ability to induce cell-to-cell fusion (syncytia) and reduced susceptibility to vaccine and infection-induced antibodies make the delta variant more infectious than previously circulating variants. The study is currently available on the bioRxiv* preprint server.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ellsworth Raymond Grant, MD 1245 Wilshire Blvd, Suite 801, Los Angeles, CA 90017-4810 Ph: (213) 481-3948 | Dr Ellsworth Raymond Grant, MD 1245 Wilshire Blvd, Suite 801, Los Angeles, CA 90017-4810 Ph: (213) 481-3948 |
News Archive
Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the company's plan to open a new office facility in Austin, Texas, April 1, 2010. The new facility provides Pioneer greater recruiting access to industry professionals who will help further the growth and development of Pioneer's Spine Division.
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited.
A new study finds surgery to transplant an ovary to the upper arm is feasible and preserves hormonal function in women undergoing treatment for cervical cancer.
WuXi PharmaTech (Cayman) Inc. today announced that it filed its annual report on Form 20-F for the year ended December 31, 2009 with the Securities and Exchange Commission.
German experts recently explained why the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant is more infectious and pathogenic than its ancestor. By conducting a series of in vitro experiments, they have revealed that increased ability to induce cell-to-cell fusion (syncytia) and reduced susceptibility to vaccine and infection-induced antibodies make the delta variant more infectious than previously circulating variants. The study is currently available on the bioRxiv* preprint server.
› Verified 7 days ago
Dr. Linda Fong, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-3290 | |
Dr. Robert Peter Gale, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 11693 San Vicente Blvd, Suite 335, Los Angeles, CA 90049 Phone: 310-442-9010 | |
Dr. Tarek Alasil, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8616 La Tijera Blvd Ste 404, Los Angeles, CA 90045 Phone: 310-673-2020 Fax: 310-469-5290 | |
David Michael Tellalian, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8635 W 3rd St Ste 465w, Los Angeles, CA 90048 Phone: 310-358-2300 Fax: 310-358-2308 | |
Dr. Jan B King, M.D., M.P.H. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 11833 Wilmington Ave Fl 2, Los Angeles, CA 90059 Phone: 323-568-8701 | |
Dr. Caroline Hwang, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1520 San Pablo St, Suite 1000, Los Angeles, CA 90033 Phone: 323-442-5100 | |
Dr. Jennifer A Fulcher, M.D., PH.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 10833 Le Conte Ave, Chs 37-121, Los Angeles, CA 90095 Phone: 310-825-7225 |